PLRX Q4 2020 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$82M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-92.2% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$19M-425.9% margin

Net Income

-$19M-426.1% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

-7.2%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$17M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$296M

Total Liabilities

$12M

Stockholders' Equity

$283M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$57M	-92.2%
Gross Profit	$4M	$57M	-92.2%
Operating Income	-$19M	$42M	-145.0%
Net Income	-$19M	$40M	-147.5%